4Front Ventures (FFNT) Investor presentation summary

Strategic market positioning and growth

• Operates as a vertically integrated cannabis company in high-growth U.S. markets, focusing on Illinois, Massachusetts, and Washington.

• Expansion in Illinois and Massachusetts leverages best-in-class operations and proven models from Washington.

• Illinois and Massachusetts markets projected to reach $2.57B and $2.28B by 2026, respectively.

• Nearly all initial production in Illinois is pre-sold or under supply agreements, ensuring strong demand.

• Strategic partnerships and retail network maximize distribution and market reach.

Operational excellence and innovation

• Implements scalable, cost-effective production methods and proprietary SOPs for high yields and quality.

• Matteson facility in Illinois features 250,000 sq ft of advanced cultivation and production space, targeting 34,800 sq ft of flowering canopy by Jan 2025.

• Massachusetts operations maintain a 100% pass rate on cultivation tests with a zero-irradiation policy.

• Washington serves as an R&D hub, piloting new products before rollout in other states.

• Product innovation includes new strains, solventless rosin, THCa isolates, and high-demand edibles.

Financial and operational performance

• Achieved 56% quarter-over-quarter wholesale revenue growth in Massachusetts and 91% year-over-year growth in October.

• Over 90% of Illinois product is pre-sold through strategic supply agreements.

• Washington operations saw record sales in Q3 2024, with 6.6% QoQ revenue growth and 20% growth in vape sales.

• Projected monthly wholesale revenue goal of $2M by Q4.

• Adjusted EBITDA reported as a key non-GAAP performance measure.